PharmTech LCGC Sciex Webinar 11.10
Feature|Videos|August 5, 2026

Meet the Panelists for the Next-Generation Bioconjugation Panel

Key Takeaways

  • Meet the panel of bioconjugate analytical experts.
  • Gain insight into each of the panelists' backgrounds and expertise.
SHOW MORE

Bioconjugate analytical experts set up for a discussion on next-generation antibody drug conjugate (ADC) characterization.

Sponsored by Waters Corporation

Colette Quinn, Senior Director and Portfolio Owner at Waters Corporation, frames the growing complexity of the bioconjugate landscape, from antibody-drug conjugates to antibody-oligonucleotide conjugates and bioconjugate vaccines. She introduces the panel of subject matter experts joining the discussion: Deanna Hunt, Senior Director of Business Development at KBI Biopharma, Lance Cadang, a scientist in Genentech’s Synthetic Molecule Analytical Chemistry division and Zhengqi Zhang, Associate Principal Scientist at Merck & Co.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.